Lafayette Hill, PA, United States of America

Jeffrey Claude Pelletier

This inventor holds 21 USPTO granted patents and 5 published patent applications and 3 EPO patents. Top assignees: Wyeth, Columbia University, Northwestern University. Active years: 1998-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffrey Claude Pelletier. Retrieved from https://idiyas.com/inventor/jeffrey-claude-pelletier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 5)

% Patents Active = 61.9

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 33(Granted Patents)

Company Filing History:

Northwestern University

patents

4. 3 out of 8

Biohaven Pharmaceutical Holding Company Limited

patents

5. 3 out of 1,496

Rutgers, The State University of New Jersey

patents

6. 2 out of 32

Biohaven Therapeutics Ltd.

patents

7. 1 out of 1

Bearsden Bearsden Bio, Inc.

Kleo Pharmaceuticals, Inc.

patents

10. 1 out of 5

Pfizer Ireland Pharmaceuticals

where one patent can have more than one assignee

Years Active: 1998-2025

Loading Chart...

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12295942 - Riluzole prodrugs and their use (2025-05-13),

2. 12172974 - Prodrugs of riluzole and their method of use (2024-12-24),

3. 12030868 - Prodrugs of CGRP antagonists (2024-07-09),

4. 12005046 - Riluzole prodrugs and their use (2024-06-11),

5. 11566016 - MAP kinase modulators and uses thereof (2023-01-31),

6. 11440893 - Prodrugs of riluzole and their method of use (2022-09-13),

7. 11149020 - MAP kinase modulators and uses thereof (2021-10-19),

8. 10844026 - Prodrugs of riluzole and their method of use (2020-11-24),

9. 10780084 - Antibody-recruiting molecules for the treatment of cancer (2020-09-22),

10. 10428047 - MAP kinase modulators and uses thereof (2019-10-01),

11. 9783525 - Map kinase modulators and uses thereof (2017-10-10),

12. 7696210 - Gonadotropin releasing hormone receptor antagonists (2010-04-13),

13. 7582636 - Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor (2009-09-01),

14. 7582634 - 7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor (2009-09-01),

15. 7538113 - 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor (2009-05-26),

Title: The Innovative Mind of Jeffrey Claude Pelletier

Introduction: Jeffrey Claude Pelletier, a talented inventor hailing from Lafayette Hill, PA (US), is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Jeffrey Claude Pelletier holds several patents in various technological domains, showcasing his versatility and creativity in inventing new solutions to complex problems.

Career Highlights: With a career spanning over two decades, Jeffrey Claude Pelletier has worked tirelessly to bring his innovative ideas to life. His dedication to pushing the boundaries of technology has led to the development of cutting-edge products that have revolutionized the industry.

Collaborations: Throughout his career, Jeffrey Claude Pelletier has collaborated with leading tech companies and research institutions to further his inventions. His ability to work in multidisciplinary teams has resulted in the successful implementation of his ideas on a global scale.

Conclusion: Jeffrey Claude Pelletier's passion for innovation and his relentless pursuit of excellence have solidified his position as a prominent figure in the world of inventors. His contributions continue to inspire future generations to think outside the box and strive for greatness in the field of technology.

Profile summary based on public USPTO records.